There is much to be discovered about control of COVID in our vulnerable transplant recipients - the issue contains both good and bad news. Dwelling on the good news, there are some early data on combined cellular and humoral response to vaccination suggesting that vaccination may be better than the gloomy initial news on sero responses. Breakthrough infections provide the bad news pointing to the continued need for good public health measures after vaccination. Elsewhere in the issue you will find news on frailty in lung transplant recipients, a major analysis of the pharmacogenetics of tacrolimus metabolism and much on liver transplant in both common and uncommon situations. Rounding out the issue there are interesting papers on PJP prophylaxis and analysis of another recombinant vaccine - this time for Herpes Zoster.
There are plenty of interesting and engaging sessions at IPITA 2021.
Here is a spotlight on some lectures you won’t want to miss!